A systematic review and meta-analysis looked at gut microbiota in people with schizophrenia compared to healthy controls. The review included 48 studies, with 14 providing data for the meta-analysis. Researchers examined alpha diversity, beta diversity, and the types of bacteria present. They found no statistically significant differences in alpha diversity measures like Shannon or Simpson indices between patients and controls. However, they did find significant differences in beta diversity, meaning the overall community structure of gut microbes was different. The review also noted a depletion of bacteria that produce short-chain fatty acids and an enrichment of pro-inflammatory bacteria in people with schizophrenia. The study did not report safety data, as it was not an intervention. A main reason to be careful is the substantial heterogeneity among studies and limited control for factors like antipsychotic medication, diet, and lifestyle. The findings suggest candidate bacteria that may be worth further study for biomarkers or microbiome-based therapies, but they do not prove cause and effect.
Systematic review and meta-analysis of gut microbiota in schizophrenia versus healthy controlsGut Microbe Differences Linked to Schizophrenia
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This systematic review and meta-analysis examined gut microbiota composition, including alpha diversity, beta diversity, and taxonomic composition, in individuals with schizophrenia compared to healthy controls. Forty-eight studies met inclusion criteria for qualitative synthesis, with 14 providing sufficient data for random-effects meta-analyses. The review did not report specific effect sizes or absolute numbers for the outcomes analyzed.
The meta-analysis found no statistically significant differences between patients and controls regarding alpha diversity indices, which included Shannon, Simpson, Chao1, ACE, and Observed measures. However, significant differences were observed in beta diversity, indicating distinct microbial community compositions between the groups. Taxonomic composition analysis showed a depletion of short-chain fatty acid-producing taxa, such as Lachnospiraceae, and an enrichment of pro-inflammatory taxa, such as Proteobacteria, in the patient group.
The authors note substantial heterogeneity and limited control for key confounders, including antipsychotic medication, diet, and lifestyle factors. These limitations suggest that the biological interpretation and causality of the observed associations require further investigation. The review highlights candidate taxa that may warrant further investigation in biomarker-focused studies and microbiome-based therapeutics.
Practice relevance is tempered by the need for cautious interpretation. The findings should be interpreted cautiously, and clinicians should avoid overstating biological interpretations or causal links based on this evidence. No safety data or adverse events were reported in the included studies.